Login / Signup

Genome-wide association meta-analysis yields 20 loci associated with gallstone disease.

Egil FerkingstadAsmundur OddssonSolveig GretarsdottirStefania BenonisdottirGudmar ThorleifssonAimee M DeatonStefan JonssonOlafur A StefanssonGudmundur L NorddahlFlorian ZinkGudny Anna ArnadottirBjarni GunnarssonGisli Hreinn HalldorssonAnna HelgadottirBrynjar O JenssonRagnar P KristjanssonGardar SveinbjornssonDavid A SverrissonGisli MassonIsleifur OlafssonGudmundur I EyjolfssonOlof SigurdardottirHilma HolmIngileif JonsdottirSigurdur OlafssonThora SteingrimsdottirThorunn RafnarEinar S BjornssonUnnur ThorsteinsdottirDaníel F GuðbjartssonPatrick SulemKári Stefánsson
Published in: Nature communications (2018)
Gallstones are responsible for one of the most common diseases in the Western world and are commonly treated with cholecystectomy. We perform a meta-analysis of two genome-wide association studies of gallstone disease in Iceland and the UK, totaling 27,174 cases and 736,838 controls, uncovering 21 novel gallstone-associated variants at 20 loci. Two distinct low frequency missense variants in SLC10A2, encoding the apical sodium-dependent bile acid transporter (ASBT), associate with an increased risk of gallstone disease (Pro290Ser: OR = 1.36 [1.25-1.49], P = 2.1 × 10-12, MAF = 1%; Val98Ile: OR = 1.15 [1.10-1.20], P = 1.8 × 10-10, MAF = 4%). We demonstrate that lower bile acid transport by ASBT is accompanied by greater risk of gallstone disease and highlight the role of the intestinal compartment of the enterohepatic circulation of bile acids in gallstone disease susceptibility. Additionally, two low frequency missense variants in SERPINA1 and HNF4A and 17 common variants represent novel associations with gallstone disease.
Keyphrases
  • genome wide association
  • systematic review
  • copy number
  • randomized controlled trial
  • autism spectrum disorder
  • anti inflammatory
  • case control